Table 3 Drug content in brain tissues and brain homogenate obtained by liquid–liquid extraction and subsequently analyzed using LC/MS/MS
Concentration (ng/mL) 24 h after injection | Concentration (ng/mL) 56 days after AD treatment | |
|---|---|---|
CLB | 5.24 ± 1.81 | N.A. |
SHAP-CLB | 16.08 ± 2.66 | 2.38 ± 0.31 |